Oramed Pharmaceuticals In...

NASDAQ: ORMP · Real-Time Price · USD
2.08
-0.04 (-1.89%)
At close: Aug 15, 2025, 3:59 PM
2.07
-0.48%
After-hours: Aug 15, 2025, 05:49 PM EDT

Oramed Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Aug 31, 2021
Net Income
5.09M -37.76M -22.99M
Depreciation & Amortization
196K 58K 77K
Stock-Based Compensation
4.21M 11.51M 2.69M
Other Working Capital
-471K -567K -3.38M
Other Non-Cash Items
-17.09M -778K 1.04M
Deferred Income Tax
n/a n/a -689K
Change in Working Capital
-2.7M -943K -1.31M
Operating Cash Flow
-10.29M -27.92M -21.18M
Capital Expenditures
-254K -496K -375K
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
-190.92M -154.41M -53.82M
Sales Maturities Of Investments
118.14M 185.09M 30.43M
Other Investing Acitivies
n/a 26K -1K
Investing Cash Flow
-73.04M 30.21M -23.76M
Debt Repayment
49.55M n/a n/a
Common Stock Repurchased
n/a n/a n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
n/a -721K 22.91M
Financial Cash Flow
51.98M 10.78M 102.89M
Net Cash Flow
-31.41M 13.01M 57.95M
Free Cash Flow
-10.55M -28.41M -21.56M